FDA recall, , High risk
Mohamed Hagar Mojo Max Fusion XXX Capsules
Mojo Max Fusion XXX contains undeclared sildenafil and tadalafil.
Summary by Recall Canary from the FDA notice
What happened
Mohamed Hagar, of Brooklyn Ctr, Minnesota, recalled Mojo Max Fusion XXX, 500 mg, one capsule per blister card, 20 count box, distributed by Max Nutrition Inc., because FDA analysis revealed undeclared sildenafil (13.1 mg/capsule) and tadalafil (13.8 mg/capsule), marketed without an approved NDA/ANDA. The recall began October 8, 2025, and the product was distributed nationwide in the U.S.
The FDA added the recall to its Enforcement Report on March 5, 2026, and it was in the weekly enforcement report on March 11, 2026. The recall involved 125 boxes.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare the details below with your product and check the FDA notice to confirm whether it is affected.
A UPC is the number printed under a barcode.
Mojo Max Fusion XXX
- UPC
- 6 78945 36675 0
- Lot code
- ALL LOTS, exp 12/31/2027
Recall details
- Company began the recall
- Sold in
U.S. Nationwide
- Company
- Mohamed HagarBrooklyn Ctr, Minnesota
- Hazard
- Hidden drug ingredient
- Risk
High risk
There is a reasonable chance that taking it could cause serious health problems or death.
FDA Class I recall · How risk is rated
- Event ID
- 97796
- Recall number
- D-0396-2026
- Quantity recalled
- 125 boxes
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report
In FDA's weekly enforcement report
Classified by FDA
Listed on Recall Canary
